rs121964980
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The ENST00000321612.8(GLDC):c.2216G>A(p.Arg739His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000292 in 1,612,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R739C) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000321612.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLDC | NM_000170.3 | c.2216G>A | p.Arg739His | missense_variant | 19/25 | ENST00000321612.8 | NP_000161.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLDC | ENST00000321612.8 | c.2216G>A | p.Arg739His | missense_variant | 19/25 | 1 | NM_000170.3 | ENSP00000370737 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000363 AC: 9AN: 247686Hom.: 0 AF XY: 0.0000374 AC XY: 5AN XY: 133700
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460010Hom.: 0 Cov.: 31 AF XY: 0.0000207 AC XY: 15AN XY: 726104
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74490
ClinVar
Submissions by phenotype
Non-ketotic hyperglycinemia Pathogenic:5
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 739 of the GLDC protein (p.Arg739His). This variant is present in population databases (rs121964980, gnomAD 0.007%). This missense change has been observed in individual(s) with GLDC-related conditions (PMID: 15824356, 16450403, 17074608; Invitae). ClinVar contains an entry for this variant (Variation ID: 11990). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GLDC protein function. Experimental studies have shown that this missense change affects GLDC function (PMID: 15824356). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 03, 2020 | Variant summary: GLDC c.2216G>A (p.Arg739His) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 247686 control chromosomes. c.2216G>A has been reported in the literature in individuals affected with Glycine Encephalopathy (Non-Ketotic Hyperglycinemia) (example, Dinopoulos_2005, Kure_2006, unpublished source from bioRxiv_2019). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Dinopoulos_2005). The most pronounced variant effect results in <10% of normal GLDC enzyme activity. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 11, 2021 | NM_000170.2(GLDC):c.2216G>A(R739H) is a missense variant classified as likely pathogenic in the context of glycine encephalopathy, GLDC-related. Please note that R739H may be associated with an attenuated form of glycine encephalopathy, GLDC-related. R739H has been observed in cases with relevant disease (PMID: 15824356, 16450403, 17074608, 27362913, 33977025, SSIEM_2005_(no PMID; abstract)). Functional assessments of this variant are available in the literature (PMID: 15824356). R739H has been observed in population frequency databases (gnomAD: NFE 0.01%). In summary, NM_000170.2(GLDC):c.2216G>A(R739H) is a missense variant that has functional support for pathogenicity and has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | GLDC: PM1, PM2, PM3, PP3, PS3:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 26, 2024 | Published functional studies demonstrate that the R739H variant had decreased enzymatic activity (PMID: 15824356); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 15824356, 16450403, 31589614, 30833958, Roa2023[Abstract], 33977025, 17074608) - |
Glycine encephalopathy 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 12, 2005 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at